Targeted imaging using ultrasound

Journal of Magnetic Resonance Imaging

Volumn 16, Issue 4, 2002, Pages 362-377

  Dayton, Paul A ^a   Ferrara, Katherine W ^a  

^a University of California   (United States)

Author keywords

Contrast agent; Microbubble; Molecular imaging; Targeted imaging; Ultrasound

Indexed keywords

ALBUNEX; CONTRAST MEDIUM; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FS 069; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LIPOSOME; M 1134; M 1136; MP 1950; MRX 113; MRX 408; MRX 408A1; NANOPARTICLE; PADGEM PROTEIN; PERFLUTREN; SHU 563A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

BLOOD FLOW; BRAIN TUMOR; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; INTRAVASCULAR ULTRASOUND; LEUKOCYTE; LIVER TUMOR; LYMPHATIC SYSTEM; MOLECULAR BIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; THROMBUS; VASCULARIZATION;

ANIMALS; BRAIN NEOPLASMS; CONTRAST MEDIA; HUMANS; INFLAMMATION; LYMPHATIC SYSTEM; MICROSPHERES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; ULTRASONOGRAPHY;

EID: 0036795486     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10173     Document Type: Review

References (96)

1. 3 for angiogenesis. Science 1994;264:569-571.
2. Van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996;74:13-33.
3. Fitzgerald D. Vascular biology of thrombosis. Neurology 2001;57:S1-S4.
4. Ismail S, Jayaweera A, Camarano G, Gimple L, Powers E, Kaul S. Relation between air-filled albumin microbubble and red blood cell rheology in the human myocardium. Circulation 1996;94:445-451.
5. de Jong N. Acoustic properties of ultrasound contrast agent. PhD dissertation, de Erasmus Universiteit, Rotterdam, 1993.
6. de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres: part one, simulations. Ultrasonics 1994;32:447-453.
7. de Jong N, Hoff L. Ultrasound scattering properties of Albunex microspheres. Ultrasonics 1993;31:175-181.
8. Wang SH, Chang PH, Shung KK, Levene HB. Some considerations on the measurements of mean frequency shift and integrated backscatter following administration of Albunex. Ultrasound Med Biol 1996;22:441-451.
9. Wilson B, Shung KK, Hete B, et al. A feasibility study on quantitating myocardial perfusion with Albunex, a ultrasonic contrast agent. Ultrasound Med Biol 1993;19:181-191.
10. Chang PH, Shung KK, Wu S, Levene HB. Second harmonic imaging and harmonic Doppler measurements with Albunex. IEEE Trans Ultrason Ferroelectr Freq Contr 1995;42:1020-1027.
11. Burns PN, Powers JE, Fritzsch T. Harmonic imaging: a new imaging and Doppler method for contrast enhanced ultrasound [abstract]. Radiology 1992;185:142.
12. Schrope BA, Newhouse VL. Second harmonic ultrasonic blood perfusion measurement. Ultrasound Med Biol 1993;19:567-579.
13. Dayton P. The effects of acoustic radiation force on contrast agents: experimental and theoretical analysis. PhD dissertation. Charlottesville: University of Virginia. 2001.
14. Goldberg BB, Raichlen JS, Forsberg F. Ultrasound contrast agents. London: Martin Dunitz: 2001.
15. Girard MS, Mattrey RF, Baker KG, Peterson T, Deiranieh LH, Steinbach GC. Comparison of standard and second harmonic B-mode sonography in the detection of segmental renal infarction with sonographic contrast in a rabbit model. J Ultrasound Med 2000;9:185-192.
16. Simpson D, Burns P. Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents. In: Proceedings of the 1997 IEEE Ultrasonics Symposium. Toronto, Canada, Oct. 5-8, 1997, p 1597-1600.
17. Morgan KE, Allen JS, Dayton PA, Chomas JE, Klibanov A, Ferrara KW. Experimental and theoretical evaluation of microbubble behavior: effect of transmitted phase and bubble size. IEEE Trans Ultrason Ferroelectr Freq Contr 2000;47:1494-1509.
18. Morgan KE. Experimental and theoretical evaluation of ultrasonic contrast agent behavior. PhD dissertation, Charlottesville: University of Virginia, 2000.
19. Chomas JE, Dayton PA, May D, Allen J, Klibanov A, Ferrara K. Optical observation of contrast agent destruction. Appl Phys Lett 2000;77:1056-1058.
20. Chomas JE, Dayton P, May D, Ferrara K. Threshold of fragmentation for ultrasonic contrast agents. J Biomed Opt 2000;6:141-150.
21. Wei K, Kaul S. Recent advances in myocardial contrast echocardiography. Curr Opin Cardiol 1997;12:539-546.
22. Mulvagh SL, DeMaria AN, Feinstein SB, et al. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 2000;13:331-342.
23. Lindner JR, Villanueva FS, Dent JM, Wei K, Sklenar J, Kaul S. Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations. Echocardiography 2000;17:25-36.
24. Forsberg F, Liu JB, Merton DA, Rawool NM, Goldberg BB. Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med 1995;14:949-957.
25. Ferrara KW, Merritt CRB, Burns PN, Foster S, Mattrey RF, Wickline SA. Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. Acad Radiol 2001;7:824-839.
26. Rocchi G, Kasprzak JD, Galema TW, de Jong N, Ten Cate FJ. Usefulness of power Doppler contrast echocardiography to identify reperfusion after acute myocardial infarction. Am J Cardiol 2001; 87:278-282.
27. Porter TR, Xie F, Kricsfeld A, Kilzer K. Noninvasive identification of acute myocardial ischemia and reperfusion with contrast ultrasound using intravenous perfluoropropane-exposed sonicated dextrose albumin. J Am Coll Cardiol 1995;26:33-40.
28. Lindner JR, Villanueva FS, Dent JM, Wei K, Sklenar J, Kaul S. Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations. Am Heart J 2000;139:231-240.
29. Wei K, Le E, Bin JP, Coggins M, Thorpe J, Kaul S. Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol 2001;37:1135-1140.
30. Federlein J, Postert T, Meves S, Weber S, Przuntek H, Buttner T. Ultrasonic evaluation of pathological brain perfusion in acute stroke using second harmonic imaging. J Neurol Neurosurg Psychiatry 2000;69:616-622.
31. Hancock J, Dittrich H, Jewitt DE, Monaghan MJ. Evaluation of myocardial, hepatic, and renal perfusion in a variety of clinical conditions using an intravenous ultrasound contrast agent (Optison) and second harmonic imaging. Heart 1998;81:636-641.
32. Chomas J, Dayton P, Morgan K, Allen J, Ferrara, K. Optimization of microbubble destruction. In: Proceedings of the 1999 IEEE Ultrasonics Symposium, Lake Tahoe, Nevada, Oct. 17-20, 1999. p 1689-1692.
33. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-483.
34. Chomas JE. The optimization of ultrasonic contrast agent destruction for the assessment of blood perfusion. PhD thesis, Charlottesville: University of Virginia, 2002.
35. Villanueva FS, Jankowski RJ, Manaugh C, Wagner WR. Albumin microbubble adherence to human coronary endothelium: implications for assessment of endothelial function using myocardial contrast echocardiography. J Am Coll Cardiol 1997;30:689-693.
36. Lindner JR, Coggins MP, Kaul S, Klibanov AL, Brandenburger GH, Ley K. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. Circulation 2000;101:668-675.
37. Lindner JR, Dayton PA, Coggins MP, et al. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 2000;102:531-538.
38. Lindner JR, Song J, Xu F, et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000;102:2745-2750.
39. 2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp Cell Res 1992;200:242-252.
40. Walzog B, Schuppan D, Heimpel C, Hafezi-Moghadam A, Gaehtgens P, Ley K. The leukocyte integrin Mac-1 (CD11b/CD18) contributes to binding of human granulocytes to collagen. Exp Cell Res 1995;218:28-38.
41. Lindner JR. Assessment of inflammation with contrast ultrasound. Prog Cardiovasc Dis 2001;44:111-120.
42. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-434.
43. Ley K. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 1996;32:733-742.
44. Dayton PA, Chomas JE, Lum AFH, et al. Optical and acoustical dynamics of microbubble contrast agents inside neutrophils. Biophys J 2001;80:1547-1556.
45. Barbarese E, Ho S-Y, D'Arrigo JS, Simon RH. Internalization of microbubbles by tumor cells in vivo and in vitro. J Neurooncol 1995;26:25-34.
46. Wakefield AE, Ho S-Y, Li X-G, D'Arrigo JS, Simon RH. The use of lipid-coated microbubbles as a delivery agent of 7β-hydroxycholesterol in a radiofrequency lesion in the rat brain. Neurosurgery 1998;42:592-598.
47. Ho S-Y, Barbarese E, D'Arrigo JS, Smith-Slatas C, Simon RH. Evaluation of lipid-coated microbubbles as a delivery vehicle for taxol in brain tumor therapy. Neurosurgery 1997;40:1260-1267.
48. Patel D, Dayton P, Gut J, Wisner E, Ferrara K. Submicron contrast agents for the detection and localization of at risk lymph nodes. In: Proceedings of the 2001 IEEE Ultrasonics Symposium, Atlanta. Georgia, Oct. 7-10, 2001, p 1717-1720.
49. Forsberg F, Goldberg BB, Liu J-B, Merton DA, Rawool NM, Shi WT. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. Radiology 1999;210:125-132.
50. Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Prog Cardiovasc Dis 2001;44:13-31.
51. Klibanov AL, Hughes MS, Marsh JN, et al. Targeting of ultrasound contrast material: an in vitro feasilibity study. Acta Radiol 1997;38:113-120.
52. Klibanov AL, Hughes MS, Wojdyla JK, et al. Targeting of ultrasound contrast material: selective imaging of microbubbles in vitro. Acad Radiol 1998;5:S243-S246.
53. Villanueva FS, Jankowski RJ, Klibanov S, et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998;98:1-5.
54. Klibanov AL, Hughes MS, Villanueva FS, et al. Targeting and ultrasound imaging of microbubble-based contrast agents. MAGMA 1999;8:177-184.
55. Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001;104:2107-2112.
56. Kanwar S, Smith CW, Kubes P. An absolute requirement for Pselectin in ischemia/reperfusion-induced leukocyte recruitment in cremaster muscle. Microcirculation 1998;5:281-287.
57. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993;91:379-387.
58. Unger EC, McCreery TP, Sweitzer RH, Shen D, Wu G. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 1998;81:58G-61G.
59. Brice J, et al. The US Diagnostic Imaging Market: Global Perspective. Diagnostic Imaging Report. San Francisco. CA: Miller Freeman: 1994.
60. Wright Jr WH, McCreery TP, Krupinski EA, et al. Evaluation of new thrombus-specific ultrasound contrast agent. Acad Radiol 1998;5:S240-S242.
61. Takeuchi M, Ogunyankin K, Pandian NG, et al. Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): in vivo experimental echocardiographic studies. J Am Soc Echocardiogr 1999;12:1015-1021.
62. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996;12:697-715.
63. Alkan-Onyuksel H, Demos SM, Lanza GM, et al. Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci 1996;85:486-490.
64. Demos SM, Onyuksel H, Gilbert J, et al. In vitro targeting of antibody-conjugated echogenic liposomes for site-specific ultrasonic image enhancement. J Pharm Sci 1997;86:167-171.
65. Demos SM, Dagar S, Klegerman M, Nagaraj A, McPherson DD, Onyuksel H. In vitro targeting of acoustically reflective immunoliposomes to fibrin under various flow conditions. J Drug Target 1998;5:507-518.
66. Demos SM, Alkan-Onyuksel H, Kane BJ, et al. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol 1999;33:867-875.
67. Huang SL, Hamilton AJ, Nagaraj A, et al. Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents. J Pharm Sci 2001;90:1917-1926.
68. Huang SL, Hamilton AJ, Pozharski E, et al. Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol. 2002;28(3):339-348.
69. Hamilton A, Huang SL, Warnick D, et al. Left ventricular thrombus enhancement following intravenous injection of echogenic immunoliposomes: studies in a new experimental model. Circulation. 2002;105(23):2772-2778.
70. Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1997;95;3334-3340.
71. Lanza GM, Wallace KD, Fischer SE, et al. High-frequency ultrasonic detection of thrombi with a targeted contrast system. Ultrasound Med Biol 1997;23:863-870.
72. Lanza GM, Abendschein DR, Hall CS, et al. In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. J Am Soc Echocardiogr 2000;13: 1-7.
73. Lanza GM, Abendschein DR, Hall CS, et al. Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest Radiol 2000;35:227-234.
74. Lanza GM, Trousil RL, Wallace KD, et al. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am 1998;104:3665-3671.
75. Hall CS, Marsh JN, Scott MJ, et al. Time evolution of enhanced ultrasonic reflection using a fibrin-targeted nanoparticulate contrast agent. J Acoust Soc Am 2000;108:3049-3057.
76. Hall CS, Marsh JN, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Temperature dependence of ultrasonic enhancement with a sitetargeted contrast agent. J Acoust Soc Am 2001;110:1677-1684.
77. Hall CS, Lanza G, Rose JH, et al. Experimental determination of phase velocity of perfluorocarbons: applications to targeted contrast agents. IEEE Trans Ultrason Ferroelectr Freq Contr 2000;47:75-84.
78. Marsh JN, Hall CS, Scott MJ, et al. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model. IEEE Trans Ultrason Ferroelectr Freq Contr 2002;49:29-38.
79. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001;104:1280-1285.
80. 3-targeted nanoparticles. Magn Reson Med 2000;44:433-439.
81. Dayton P, Klibanov A, Brandenburger G, Ferrara K. Acoustic radiation force in vivo: a mechanism to assist the targeting of microbubbles. Ultrasound Med Biol 1999;25:1195-1201.
82. Dayton PA, Morgan KE, Klibanov SA, Brandenburger GH, Nightingale K, Ferrara KW. A preliminary evaluation of the effects of primary and secondary radiation forces on acoustic contrast agents. IEEE Trans Ultrason Ferroelectr Freq Contr 1997;44:1264-1277.
83. Leong-Poi H, Klibanov AL, Christiansen, JP, Huo Y, Linder JR. Development of an angiogenesis-targeted microbubble ultrasound contrast agent. Presented at the 51st Scientific Session, American College of Cardiology Meeting, Atlanta. Georgia. March 17-20, 2002.
84. Lindner JR, Kaul S. Delivery of drugs with ultrasound. Echocardiography 2001;18:329-337.
85. Unger EC, Hersh E, Vannan M, Matsunaga TO, McCreery T. Local drug and gene delivery through microbubbles. Prog Cardiovasc Dis 2001;44:45-54.
86. Unger UC, McCreery TP, Sweitzer BS, Caldwell VE, Wu Y. Acoustically active lipospheres containing Paclitaxel: a new therapeutic contrast agent. Invest Radiol 1998;33:886-892.
87. Klibanov AL. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev 1999;37:139157.
88. May D, Dayton P, Chomas J, Allen J, Ferrara K. Ultrasound contrast agents used for localized drug delivery. In: Proceedings of the 2001 IEEE Ultrasonics Symposium, Atlanta, Georgia, Oct. 7-10, 2001. p 1385-1389.
89. Price RJ, Skyba DM, Kaul S, Skalak TC. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 1998;98:1264-1267.
90. Lawrie A, Brisken AF, Francis SE, Cumberland DC, Crossman DC. Newman CM. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Therapy 2000;7:2023-2027.
91. Shohet RV, Chen S, Zhao Y, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000;101:2554-2556.
92. Porter TR, LeVeen RF, Fox R, Kricsfeld A, Xie F. Thrombolytic enhancement with perfluorocarbon exposed sonicated dextrose albumin microbubbles. Am Heart J 1996;132:964-968.
93. Dhond MR, Nguyen TT, Pulido G, Bommer WJ. Ultrasound-enhanced thrombolysis at 20 kHz with air-filled and perfluorocarbonfilled contrast bispheres. J Am Soc Echocardiogr 2000;13:1025-1029.
94. Wu Y, Unger E, McCreery TP, et al. Binding and lysing of blood clots using MRX-408. Invest Radiol 1998;33:880-885.
95. Miller DL, Quddus J. Sonoporation ofmonolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med Biol 2000;26:661-667.
96. Ward M, Wu J, Chiu JF. Experimental study of the effects of Optison concentration on sonoporation in vitro. Ultrasound Med Biol 2000;1169-1175.